These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
476 related articles for article (PubMed ID: 9288768)
21. Abnormalities of fragile histidine triad genomic and complementary DNAs in cervical cancer: association with human papillomavirus type. Muller CY; O'Boyle JD; Fong KM; Wistuba II; Biesterveld E; Ahmadian M; Miller DS; Gazdar AF; Minna JD J Natl Cancer Inst; 1998 Mar; 90(6):433-9. PubMed ID: 9521167 [TBL] [Abstract][Full Text] [Related]
22. FHIT gene and flanking region on chromosome 3p are subjected to extensive allelic loss in Egyptian breast cancer patients. Ismail HM; Medhat AM; Karim AM; Zakhary NI Mol Carcinog; 2011 Aug; 50(8):625-34. PubMed ID: 21557333 [TBL] [Abstract][Full Text] [Related]
23. Precise localization of the FHIT gene to the common fragile site at 3p14.2 (FRA3B) and characterization of homozygous deletions within FRA3B that affect FHIT transcription in tumor cell lines. Ong ST; Fong KM; Bader SA; Minna JD; Le Beau MM; McKeithan TW; Rassool FV Genes Chromosomes Cancer; 1997 Sep; 20(1):16-23. PubMed ID: 9290949 [TBL] [Abstract][Full Text] [Related]
24. Alterations of the FHIT gene in human hepatocellular carcinoma. Yuan BZ; Keck-Waggoner C; Zimonjic DB; Thorgeirsson SS; Popescu NC Cancer Res; 2000 Feb; 60(4):1049-53. PubMed ID: 10706123 [TBL] [Abstract][Full Text] [Related]
25. Reciprocal translocations in breast tumor cell lines: cloning of a t(3;20) that targets the FHIT gene. Popovici C; Basset C; Bertucci F; Orsetti B; Adélaide J; Mozziconacci MJ; Conte N; Murati A; Ginestier C; Charafe-Jauffret E; Ethier SP; Lafage-Pochitaloff M; Theillet C; Birnbaum D; Chaffanet M Genes Chromosomes Cancer; 2002 Nov; 35(3):204-18. PubMed ID: 12353263 [TBL] [Abstract][Full Text] [Related]
26. Genomic FHIT analysis in RER+ and RER- adenocarcinomas of the pancreas. Hilgers W; Groot Koerkamp B; Geradts J; Tang DJ; Yeo CJ; Hruban RH; Kern SE Genes Chromosomes Cancer; 2000 Mar; 27(3):239-43. PubMed ID: 10679912 [TBL] [Abstract][Full Text] [Related]
27. [Loss of fragile histidine triad expression and metastasis in breast cancer]. Zhao P; Li XY; Chen LZ Ai Zheng; 2002 Jun; 21(6):668-70. PubMed ID: 12452072 [TBL] [Abstract][Full Text] [Related]
28. The FHIT gene at 3p14.2 is abnormal in breast carcinomas. Negrini M; Monaco C; Vorechovsky I; Ohta M; Druck T; Baffa R; Huebner K; Croce CM Cancer Res; 1996 Jul; 56(14):3173-9. PubMed ID: 8764101 [TBL] [Abstract][Full Text] [Related]
30. Frequent abnormalities of the putative tumor suppressor gene FHIT at 3p14.2 in pancreatic carcinoma cell lines. Simon B; Bartsch D; Barth P; Prasnikar N; Münch K; Blum A; Arnold R; Göke B Cancer Res; 1998 Apr; 58(8):1583-7. PubMed ID: 9563464 [TBL] [Abstract][Full Text] [Related]
31. The FHIT and PTPRG genes are deleted in benign proliferative breast disease associated with familial breast cancer and cytogenetic rearrangements of chromosome band 3p14. Panagopoulos I; Pandis N; Thelin S; Petersson C; Mertens F; Borg A; Kristoffersson U; Mitelman F; Aman P Cancer Res; 1996 Nov; 56(21):4871-5. PubMed ID: 8895736 [TBL] [Abstract][Full Text] [Related]
32. Molecular analysis of the FHIT gene in human prostate cancer. Latil A; Bièche I; Fournier G; Cussenot O; Pesche S; Lidereau R Oncogene; 1998 Apr; 16(14):1863-8. PubMed ID: 9583683 [TBL] [Abstract][Full Text] [Related]
33. Structure and expression of the human FHIT gene in normal and tumor cells. Druck T; Hadaczek P; Fu TB; Ohta M; Siprashvili Z; Baffa R; Negrini M; Kastury K; Veronese ML; Rosen D; Rothstein J; McCue P; Cotticelli MG; Inoue H; Croce CM; Huebner K Cancer Res; 1997 Feb; 57(3):504-12. PubMed ID: 9012482 [TBL] [Abstract][Full Text] [Related]
34. Contig array CGH at 3p14.2 points to the FRA3B/FHIT common fragile region as the target gene in diffuse large B-cell lymphoma. Kameoka Y; Tagawa H; Tsuzuki S; Karnan S; Ota A; Suguro M; Suzuki R; Yamaguchi M; Morishima Y; Nakamura S; Seto M Oncogene; 2004 Dec; 23(56):9148-54. PubMed ID: 15480422 [TBL] [Abstract][Full Text] [Related]
35. Molecular analysis of the FHIT gene at 3p14.2 in lung cancer cell lines. Yanagisawa K; Kondo M; Osada H; Uchida K; Takagi K; Masuda A; Takahashi T; Takahashi T Cancer Res; 1996 Dec; 56(24):5579-82. PubMed ID: 8971157 [TBL] [Abstract][Full Text] [Related]
36. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation. Wali A; Srinivasan R; Shabnam MS; Majumdar S; Joshi K; Behera D Mol Cancer Res; 2006 Feb; 4(2):93-9. PubMed ID: 16513840 [TBL] [Abstract][Full Text] [Related]
37. Loss of FHIT function in lung cancer and preinvasive bronchial lesions. Sozzi G; Pastorino U; Moiraghi L; Tagliabue E; Pezzella F; Ghirelli C; Tornielli S; Sard L; Huebner K; Pierotti MA; Croce CM; Pilotti S Cancer Res; 1998 Nov; 58(22):5032-7. PubMed ID: 9823304 [TBL] [Abstract][Full Text] [Related]
38. Induction of the common fragile site FRA3B does not affect FHIT expression. Michael D; Rajewsky MF Oncogene; 2001 Mar; 20(14):1798-801. PubMed ID: 11313927 [TBL] [Abstract][Full Text] [Related]
39. High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele loss. Maitra A; Wistuba II; Washington C; Virmani AK; Ashfaq R; Milchgrub S; Gazdar AF; Minna JD Am J Pathol; 2001 Jul; 159(1):119-30. PubMed ID: 11438460 [TBL] [Abstract][Full Text] [Related]
40. Evidence that instability within the FRA3B region extends four megabases. Becker NA; Thorland EC; Denison SR; Phillips LA; Smith DI Oncogene; 2002 Dec; 21(57):8713-22. PubMed ID: 12483524 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]